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Abstract 
Background: In the current study, a transient cerebral ischemia producing selective cell death was designated a mild 
ischemic insult. A comparable insult in humans is a transient ischemic attack (TIA) that is associated with functional 
recovery but can have imaging evidence of minor ischemic damage including cerebral atrophy. A TIA also predicts a 
high risk for early recurrence of a stroke or TIA and thus multiple ischemic insults are not uncommon. Not well under-
stood is what the effect of differing recovery times between mild ischemic insults has on their pathophysiology. We 
investigated whether cumulative brain damage would differ if recurrence of a mild ischemic insult occurred at 1 or 3 
days after a first insult.
Results: A transient episode of middle cerebral artery occlusion via microclip was produced to elicit mild ischemic 
changes—predominantly scattered necrosis. This was followed 1 or 3 days later by a repeat of the same insult. Brain 
damage assessed histologically 7 days later was substantially greater in the 1 day recurrent group than the 3 days 
recurrent group, with areas of damage consisting predominantly of regions of incomplete infarction and pannecrosis 
in the 1 day group but predominantly regions of selective necrosis and smaller areas of incomplete infarction in the 
3 days group (P < 0.05). Enhanced injury was reflected by greater number of cells staining for macrophages/microglia 
with ED1 and greater alterations in GFAP staining of reactive astrocytes in the 1 day than 3 days recurrent groups. The 
differential susceptibility to injury did not correspond to higher levels of injurious factors present at the time of the 
second insult such as BBB disruption or increased cytokines (tumor necrosis factor). Microglial activation, with poten-
tial for some beneficial effects, appeared greater at 3 days than 1 day. Also blood analysis demonstrated changes 
that included an acute increase in granulocytes and decrease in platelets at 1 day compared to 3 days post transient 
ischemia.
Conclusions: Dynamic changes in multiple inflammatory responses likely contribute to the time dependence of 
the extent of damage produced by recurrent mild ischemic insults. The time of mild stroke recurrence is crucial with 
early recurrence producing greater damage than subacute recurrence and this supports urgency for determining and 
implementing optimal stroke management directly after a TIA.
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Background
Ischemic stroke remains a leading cause of death and a 
major cause of adult disability resulting in a huge personal, 
social and economic burden [1]. Often considered a warn-
ing sign for stroke, a transient ischemic attack (TIA) 
results from a cerebral ischemic episode of short duration 
associated with a temporary blockage of a cerebral artery 
resulting in transient (less than 24 h) functional deficits [2, 
3]. Although TIA’s are associated with substantial or full 
functional recovery, there is both experimental and clini-
cal evidence that reperfused brain may often suffer some 
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permanent damage such as scattered cell death or selec-
tive neuronal loss following a transient ischemic event 
[4–7]. Understanding better the pathophysiology of such 
mild transient ischemic injury is of some urgency consid-
ering an anticipated higher incidence of TIA as the popu-
lation becomes increasingly elderly, and, an anticipated 
increasing number of transient cerebral artery occlusions 
will be successfully recanalized with tissue plasminogen 
activator or endovascular therapy [8–10].
In addition to being key to treatment approaches, 
improved knowledge regarding the pathophysiology of a 
relatively short transient ischemic insult resulting in recov-
ery is also of importance for understanding the interactions 
of multiple events considering that a TIA is associated with 
an increased risk of a second or recurrent stroke [2, 3, 11]. 
A majority of TIA’s are associated with cortical ischemic 
events and large vessel disease and recurrence is most com-
monly associated with a second ipsilateral cortical ischemic 
event [12, 13]. However, surprisingly little is known of the 
interaction of the ischemic injury processes that occur 
with multiple mild ischemic insults where the insults are 
sufficiently severe to cause selective cell death within the 
ischemic territory. Duration between insults is likely a cru-
cial factor considering that ischemic injury and brain recov-
ery evolve over time. Furthermore, the pathophysiology of 
early recurrence is important to understand considering 
recurrence is frequently observed by 1 day after a TIA [14].
Thus the objective of the current study was to deter-
mine whether cumulative damage from multiple mild 
transient ischemic insults, each of sufficient severity 
to cause selective necrosis, is influenced by the recov-
ery time between insults. A secondary objective was to 
determine whether the evolution of cellular changes after 
the first insult were associated with the total damage 
produced by the recurrent insult. We hypothesized that 
damage with an early recurrent stroke would be greater 
than with a subacute recurrent stroke. An animal model 
was considered key because ischemic severity could 
be varied to produce mild ischemic cerebral changes 
as can be observed clinically. Furthermore the timing 
between insults could be well controlled. Thus we used 
a rat model of transient focal ischemia [7, 15] adjusted to 
produce selective cell death, which in young Wistar rats 
required 30 min of occlusion; this was designated to be a 
mild transient cerebral ischemic insult. We also produced 
a recurrence of the insult at 1 or 3 days with the results 
demonstrating that brain damage is greater when recur-
rence is acute (1 day) rather than subacute (3 days).
Methods
Male Wistar rats (Charles River, Montreal, Canada) 
were acclimatized to a 12  h light/dark cycle with free 
access to food and water. Animals were randomized 
to one of three groups involving double surgical proce-
dures: a control group with sham surgery  +  transient 
middle cerebral artery occlusion (MCAO) at 1  day and 
experimental groups with MCAO + recurrent MCAO at 
1 day and MCAO + recurrent MCAO at 3 days (n = 6/
group). Sample size was selected to minimize num-
bers of animals used yet provide power as estimated to 
detect a 30 % difference between the anticipated means 
of groups assuming a standard deviation of 15  %. Ani-
mals were euthanized 7  days after the last surgery and 
brains were processed for histology to determine the 
extent of ischemic brain damage. In additional experi-
ments performed to investigate longitudinal cerebral 
ischemic changes, animals were randomized to MCAO 
and euthanasia at 1 or 3 days after the transient ischemia 
(n = 8/group). Peripheral systemic inflammatory changes 
were also investigated in additional animals from blood 
sampled at either 1 or 3 days following transient MCAO 
(n = 5/group).
Transient mild focal ischemic insult
Surgical procedures were performed aseptically under 
isoflurane anesthesia and included analgesic measures to 
alleviate suffering. On the day of the first surgery, a tran-
sient mild ischemic insult (mild transient MCAO) was 
produced in the laboratory by temporarily occluding the 
distal MCA using a microsurgical approach as described 
previously [7, 15]. Briefly, a microaneurysm clip was 
placed on the MCA through a small burr hole in the tem-
poral bone above the MCA where it crosses the rhinal 
fissure. Rectal temperature was maintained using a servo-
controlled heating lamp. A tail artery was cannulated for 
obtaining arterial blood samples and a small burr hole 
over the ipsilateral parietal cortex was used to measure 
cerebral perfusion with laser Doppler flowmetry. Con-
current to the MCAO, both common carotid arteries 
were transiently occluded using suture thread. At the end 
of the 30 min occlusion, the microclip and carotid artery 
ligatures were removed. A dura substitute (Gore Pre-
clude MVP, Better Hospital Supplies Corp., Miami, FL) 
was positioned on closing to facilitate the production of 
a subsequent second MCAO. Topical anesthetic in addi-
tion to the administration of buprenorphine (0.03  mg/
kg, s.c. every 12 h as needed) provided analgesia. During 
a sham operation, animals underwent the same surgical 
procedures with the exception of vascular occlusion. Fol-
lowing surgery, rats were housed in separate cages with 
free access to soft and hard food, water and environ-
mental enrichment. Animals were monitored twice daily 
for the first 2 days and then daily to ensure good recov-
ery. Animals were subjected to a recurrent mild focal 
ischemic insult by repeating the 30  min MCAO proce-
dure at either 1 or 3 days of recovery following the initial 
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mild MCAO. The location of the second clip placement 
on the MCA was immediately distal to the original posi-
tion to minimize surgical complications.
Histology to detect brain injury or repair responses
For histological analysis, pentobarbital anesthetized 
rats were perfusion fixed with formalin and brains were 
embedded in paraffin. Sections (6 μm) were stained with 
standard and immunohistochemical methods and altered 
staining or ischemic injury were assessed blinded to the 
animal’s identification or surgical group.
Standard staining with hematoxylin and eosin
In sections stained with hematoxylin and eosin, the 
extent of cortical damage was identified by classifying 
ischemic injury in the ischemic middle cerebral artery 
territory as selective necrosis, incomplete infarction or 
pannecrosis as described in previous studies [5, 16]. In 
addition, a score for brain injury was determined [7] by 
dividing the cortex into 4 regions of interest and a score 
was assigned to each region graded as: 0 for normal, 1 for 
<10 % of cellular injury, 2 for 10–50 % of cellular injury, 3 
for >50 % cellular injury and, 4 for confluent areas of pan-
necrosis. A cumulative score was obtained by summing 
the scores for each region.
Immunohistochemical staining for cellular ischemic 
changes
Macrophages/microglia and astrocytes are two glial cell 
types participating in the CNS inflammatory response 
to cerebral ischemia. The ischemic changes in these 
cells observed following 7  days of recovery after multi-
ple ischemic insults also reflect the severity of ischemic 
injury. Reactive astrocytes were assessed using a primary 
antibody to glial fibrillary acidic protein (GFAP) (rabbit 
anti-GFAP, 1:10,000, AB_10013482, Dako, Burlington, 
ON). Increased activation of macrophages/microglia were 
assessed using anti-ED1 (AB_2291300, mouse anti-rat 
CD68 clone ED1, 1:100, AbD Serotec, Raleigh, NC) [17].
The effect of a single mild ischemic insult on the pro-
gression of inflammatory changes between 1 and 3 days 
were assessed first by staining for reactive astrocytes 
and macrophages/microglia as above. Changes in the 
cytokine, tumor necrosis factor (TNF) was assessed using 
goat anti rat TNF-alpha (1:100, AB_354511, R&D system, 
Minneapolis, MN) [17]. In addition, early activation of 
microglia was assessed using an antibody against Ion-
ized Calcium-Binding Adapter Molecule 1 (Iba1, 1:1000, 
AB_839504, Wako Chemicals, USA) which is specifically 
expressed in microglia and is upregulated following cer-
ebral ischemia [18].
Vascular changes were investigated using a fluo-
rescein isothiocyanate-labeled tomato lectin (1:200, 
AB_2307440, Vector Laboratories Burlingame, CA) that 
stains both microglia and vessels [19]. The same sec-
tions stained for lectin were also stained using a primary 
mouse anti-rat endothelial barrier antigen (EBA) IgM 
(AB_10120605, SMI 71, 1:400, Covance) that stained 
vessels [20] to assess blood–brain barrier dysfunction. 
Comparing EBA and lectin stained sections provided 
an additional detection of morphological and intensity 
staining changes in microglia. Finally, integrity of the 
blood–brain barrier was assessed using an antibody to 
detect extravasation of large plasma proteins (1:200, goat 
anti rat immunoglobulin G (IgG), Jackson ImmunoRe-
search Lab, West Grove, PA).
For all the immunohistochemical stains, methods 
were generally as described previously [7]. Briefly, par-
affin sections were first processed for antigen retrieval 
using citrate buffer at pH = 6, an exception being sec-
tions stained with Iba1. The sections were incubated 
with either 10  % goat or donkey serum, then primary 
antibody, followed by the appropriate biotin-conju-
gated IgG (Jackson ImmunoResearch Lab, West Grove, 
PA) or fluorescent conjugated secondary antibody. For 
colorimetric staining, horseradish peroxidase conju-
gated streptavidin (1:400, Dako, Burlington, ON) and 
diaminobenzidine (Sigma) were applied. For double 
staining of lectin and EBA, antigen retrieval was omit-
ted and after blocking with goat serum sections were 
incubated with FITC-lectin at room temperature for 
1 h followed by incubation with EBA at room tempera-
ture overnight.
Histological analysis of altered immunostaining
Sections were visualized and analyzed blinded to the 
experimental group using an Olympus BX61 micro-
scope and Microbrightfield Stereo Investigator (MBF 
Bioscience, Williston, VT). Immunohistochemical 
changes were semi-quantified according to the stain 
used and the types of cellular changes observed in the 
MCA territory of the parietal cortex ipsilateral and con-
tralateral to the transient occlusion. For ED1 and TNF, 
regions of parietal cortex within the MCA territory 
were inspected and cells within at least three fields of 
view (0.263 mm2 each) with positive staining for ED1 or 
TNF were counted and used to provide a mean value. 
For EBA, fluorescent images of parietal cortex were 
captured digitally (200× magnification) and those with 
technically good vessel staining in the contralateral 
hemisphere were analyzed using Image J for counting 
of the number of EBA stained vessels in representa-
tive ipsilateral and contralateral fields of view. GFAP 
stained sections were assigned cumulative scores simi-
lar to the hematoxylin and eosin stained sections, with 
altered levels of staining being scored in each of the four 
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different cortical areas as: 0 for normal, 1 for scattered 
reactive cells labelled or <10  % of area, 2 for 10–50  % 
of the area labelled, 3 for >50  % of the area labelled 
and 4 for confluent areas of pannecrosis with total loss 
of GFAP stain. A lectin staining score was attained by 
assessing the extent of increased tomato lectin staining 
of activated microglia and their processes within the 
cortical parenchyma (i.e. in excess of vessels labelled 
with EBA) and scored according to: 0—none, 1—sparse 
numbers and 2—substantial numbers of parenchymal 
cells with positive lectin staining. In regions of infarct 
a score of 3 was assigned if there were substantial num-
bers of positive stained parenchymal cells in addition to 
a diffuse increase in signal from within the parenchyma. 
For Iba1 stained sections, those with the best positive 
staining of processes were selected for counting both 
the total number of microglial cells stained per field and 
the number of activated microglial cells with ramified or 
thickened bushy processes. Potential increased colori-
metric staining in cortex for plasma proteins with IgG 
were assessed by measuring gray levels in ipsilateral and 
contralateral cortex along with levels on the blank slide 
adjacent to the region of interest in order to analyze 
left–right differences.
Systemic circulatory response
Hematology analysis of blood samples was also per-
formed in additional rats to assess for signs of immuno-
suppression or infection. Venous blood samples (0.2 ml) 
were collected in EDTA coated tubes and analyzed 
immediately for concentrations of platelets and red and 
white blood cells (HemaTrue Hematology Analyzer, 
Heska Corp., Loveland, CO, USA). Relative proportions 
of the different types of white cells were also assessed by 
measuring the numbers of monocytes, granulocytes and 
lymphocytes.
Statistical analysis
Data were analyzed using SigmaPlot 13 software (Sys-
tat Software Inc, San Jose, CA). Data are reported as 
mean ± SD for groups with continuous values or as the 
median and first and third quartiles for nonparametric 
data. Statistical comparisons were considered significant 
at P < 0.05. Prior to a comparison of means, samples were 
first tested for normality and equal variance followed by 
selection of an appropriate analysis of variance and post 
hoc test (e.g. Bonferroni). Differences between ipsilateral 
and contralateral hemispheres were compared using a 
paired Student’s t-test or a Rank Sum Test for categorical 
values.
Results
Brain damage varies with timing between multiple mild 
insults
For animals receiving multiple surgical interventions, eight 
animals were lost to analysis due to mortality post recurrent 
stroke (n = 1), inadequate flow reduction during clip place-
ment (n =  2), surgical complications (n =  2) and a prob-
lem with tissue embedding (n =  2). A total of 18 animals 
(n = 6/group) were analyzed in the sham + mild MCAO, 
1  day recurrent MCAO and 3  days recurrent MCAO 
groups. Body weights in these 3 groups were similar at base-
line and time of the second surgery (290 ± 65 and 282 ± 50; 
319 ±  56 and 314 ±  65; 296 ±  45 and 296 ±  40, respec-
tively). In all animals, ischemic changes were observed in the 
cerebral cortex ipsilateral to the transient middle cerebral 
artery occlusion (Fig. 1b, d, e–h) but not in the contralat-
eral cortex (Fig.  1a, c). Severity of injury varied between 
groups (see also data in Additional file 1). Substantial areas 
of incomplete infarct and pannecrosis in addition to some 
areas of selective necrosis were apparent within the middle 
cerebral artery territory in all 6 animals subjected to a recur-
rent mild ischemic insult separated by 1  day (e.g. Fig.  1b, 
d). Substantial changes in ED1 and GFAP staining also 
occurred with recurrence at 1 day post first insult (Fig. 1j, l 
and o, q, respectively). In contrast, in animals subjected to 
a recurrent mild ischemic insult separated by 3 days there 
were only small regions of incomplete infarction with more 
extensive regions of selective necrosis in four of the six ani-
mals and only regions of selective necrosis in 2 animals (e.g. 
Fig. 1e, g). Positive staining of macrophages/microglia with 
ED1 or for reactive astrocytes with GFAP was also modest 
(Fig. 1k, m, p, r). Brains of animals that underwent a sham 
procedure followed by transient ischemia 1 day later had the 
least extensive ischemic changes consisting of only selective 
necrosis (6/6 animals) (e.g. Fig. 1f, h) and minimal staining 
for ED1 or GFAP (3/3) (Additional file 1).
Semi-quantitative analysis of the stained sections sup-
ported these observations (Fig. 1i). All groups had signifi-
cantly greater damage (median cumulative score ≥3) in 
the ischemic cortex than in the contralateral hemisphere 
which was normal (median score of 0). Animals with an 
early recurrent stroke 1 day after the first insult had sig-
nificantly greater damage assessed in hematoxylin and 
eosin stained sections than a sham procedure followed 
by a mild MCAO. Total damage with early (1 day) recur-
rence also exceeded that produced by recurrent stroke 
separated by 3 days (P < 0.05). The differences in sever-
ity of damage and their dependence on the recovery time 
between the first and recurrent insult were also reflected 
in an increased number of cells staining with ED1 
Page 5 of 14Tuor et al. BMC Neurosci  (2016) 17:28 
(Fig. 1n) and the severity score for differences in staining 
for reactive astrocytes with GFAP (Fig. 1s).
Similar physiological measures in recurrent stroke groups
Potential differences in severity of ischemia or other 
measured physiological parameters that are well known 
to affect ischemic injury were comparable between 
groups. Cortical perfusion was less than 10  % baseline 
during MCAO and reperfusion levels were similar dur-
ing both the first and second ischemic insult irrespective 
of the recovery time between them (Fig.  2a). There was 
also excellent control of body temperature during MCAO 
and during early reperfusion, irrespective of the experi-
mental group (Fig. 2b). Other physiological variables and 
blood gases were similar between 1 and 3 days recurrent 
groups. Mean values were 86 ± 11 and 88 ± 11 mm Hg 
for mean arterial blood pressure, 102 ±  7 and 109 ±  5 
for PO2, 44.2  ±  2 and 38.6  ±  2  mm Hg for PCO2, 
7.35  ±  0.01 and 7.36  ±  0.04 for PH and 13.6  ±  3 and 
11.6 ± 2 mmol/L for blood glucose, respectively. See also 
data in Additional file 2.
Inflammatory changes following a single mild transient 
ischemia
In order to investigate whether differential responses to 
brain injury and recovery from ischemia could explain 
the ensuing damage produced by a recurrent MCAO, 
longitudinal tissue changes to a single mild MCAO were 
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Fig. 1 Cerebral injury dependence on recovery time between recurrence of mild transient ischemic insults. Representative cerebral cortical micro-
graphs of sections at low and high magnification (scale bar of 25 µm) stained with: hematoxylin and eosin (a–h), ED1 for activated macrophages/
microglia (j–m), and GFAP for reactive astrocytes (o–r). Brain was perfusion fixed and processed 7 days following the last insult. Cerebral cortex con-
tralateral to the transient middle cerebral artery occlusion (MCAO) is normal (A,C). Within cerebral cortex (b, d) after a mild transient MCAO followed 
by a recurrent MCAO at 1 day there is extensive pannecrosis (p). Selective necrosis (s) is common following a mild transient MCAO followed by a 
recurrent MCAO at 3 days (e, g). Selective necrosis also occurs in rats with a sham surgery followed 1 day later by transient MCAO (f, h). Semiquanti-
tative assessment of injury scores indicated greater damage with 1 day compared to 3 days recurrence in the H&E sections (i). Immunohistochemi-
cal staining with ED1 antibody demonstrated an increase in activated macrophages/microglia following recurrent MCAO produced at either 1 or 
3 days after an initial MCAO (j–m). The mean number of cells per field with ED1 staining demonstrating a difference between 1 and 3 days recurrent 
MCAO groups (n). GFAP staining of astrocytes was increased with recurrent MCAO at 1 or 3 days (o–r). The median score for altered GFAP staining 
reflected greater injury and astrocytic changes in brains of animals with recurrent MCAO at 1 day than 3 days (s). n = 6/group. *P < 0.05; **P < 0.006, 
Ipsilateral different from contralateral; †P < 0.05; ††P < 0.006, different from 1 day Recurrent MCAO. ‡P < 0.01, different from Sham
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investigated in additional randomized animals. Several 
of these were lost to analysis due to mortality (n  =  1), 
surgical complications (n  =  2) and a problem with tis-
sue embedding (n  =  1). Sections from all animals ana-
lyzed following a single transient MCAO demonstrated 
mild damage in hematoxylin and eosin stained sections 
(Fig. 3a, b). Damage score was similar in the 1 and 3 days 
recurrent MCAO groups (n = 8/group) (Fig. 3c). In adja-
cent stained sections, there were increased numbers of 
ED1 stained macrophages/microglia ipsilaterally in both 
groups (Fig. 3d, e). There was also altered GFAP staining 
of reactive astrocytes (Fig. 3g, h) compared to contralat-
eral cortex. These inflammatory changes scored in the 1 
and 3  days recurrent groups were not different statisti-
cally (Fig. 3f, i). See also data in Additional file 3.
In sections from these animals we also investigated 
whether TNF-alpha, often considered to be a pro-inflam-
matory cytokine, is substantially increased 1 day post a 
mild ischemic insult and thereby a potential contributor 
to increased ischemic damage observed with multiple 
insults at this time. Relative to the contralateral cortex, 
which had minimal TNF staining (Fig.  4a), increased 
numbers of positive TNF stained cells were observed 
ipsilaterally at 1 and 3  days post-insult (e.g. Fig.  4b, c). 
The mean increased number of TNF stained cells were 
not different statistically at 1 and 3  days post insult 
(Fig. 4d). See also data in Additional file 4.
Microglial changes, which are usually considered pro-
inflammatory acutely but can also contribute later to 
repair [21], were altered following a single mild insult. 
Microglial cells stained with Iba1 (Fig. 4e–h) were simi-
lar in the 1 and 3 days groups contralaterally (e.g. mean 
of 23.0 ± 6.0 cells per field). Total numbers of cells ipsi-
laterally increased to 32.4  ±  9 and 64.9  ±  25 in the 1 
and 3  days groups respectively (P  <  0.05) and included 
cells with ramified or bushy morphology or round cells 
(Fig.  4f, g). Those with ramified or bushy morphology 
were also different between groups (Fig.  4h). See also 
data in Additional file  4. Using a tomato lectin stain of 
vessels and microglia, examination of staining in the 
non-vascular parenchyma contralaterally indicated a 
lack of appreciable staining for microglial cells with lec-
tin [22] (e.g. Fig.  4i). At 1  day post MCAO there was a 
modest increase in lectin stained microglia and their pro-
cesses, associated with microglial activation (e.g. Fig. 4j). 
At 3  days post-insult, substantial numbers of microglia 
stained for lectin (e.g. Fig.  4k) and the median scores 
for lectin staining differed significantly between groups 
(P < 0.05) (Fig. 4l).
BBB injury following a mild transient ischemia
In sections stained with lectin, we also performed 
immunostaining for endothelial barrier antigen (EBA) 
whose loss is considered to provide a highly sensitive 
indicator of dysfunction of the blood–brain barrier [20]. 
There was reduced vascular EBA immunoreactivity 
observed following a mild ischemic insult. Compared to 
the contralateral hemisphere (Fig. 4m), there were fewer 
EBA stained vessels (Fig. 4n–o) and analysis of sections 
determined a reduced number of EBA stained vessels 
both at 1 and 3 days post a mild MCAO (Fig. 4p). There 
was no significant difference between groups. Despite 
a reduction in EBA staining there was no evidence of 
major BBB damage. Following a single mild ischemic 
insult, there was a lack of appreciable positive staining 
for IgG within parietal cortex (not shown), indicating 
that the blood–brain barrier was intact to passage of 
large plasma proteins detectable with IgG. Quantita-
tive analysis of these sections demonstrated there was 
no difference in the darkness of staining in ipsilateral 
versus contralateral cortex for the 1 and 3 days groups 
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Fig. 2 Mean cortical perfusion or rectal temperature during or post 
middle cerebral artery occlusion (MCAO). a Cortical perfusion meas-
ured using Doppler flowmetry presented as a percent of baseline. 
Mean perfusion decreased to <8 % baseline during MCAO subse-
quently returning toward baseline within the first 5 min following 
reperfusion irrespective of MCAO recurrence at either 1 or 3 days post 
the first MCAO (n = 6/group). b Mean core body temperature was 
well controlled resulting in similar means for the recurrent groups 
either during or after the first or second MCAO
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Systemic inflammation following a mild transient ischemia
Considering the evidence that systemic inflammation 
or suppression of the immune system can play a role in 
influencing ischemic damage [21, 23, 24], we also investi-
gated the potential contribution of systemic immune cell 
changes to the enhancement of ischemic damage by per-
forming a hematology analysis of blood samples collected 
at 1 or 3 days following a mild MCAO or a sham surgery. 
Blood samples from a naïve group of rats provided an 
additional control (n  =  5/group). Groups had a simi-
lar hematocrit (Fig.  5d and Additional file  5). Following 
a mild MCAO there was a decrease in the lymphocyte 
percentage of white blood cells and the platelet concen-
tration at 1 day but not 3 days relative to naïve controls 
(Fig. 5a, b). In contrast, there was a transient increase in 
the granulocyte percentage of white blood cells at 1 day 
compared to levels either in naïve animals or in blood 
samples collected 3  days after MCAO (Fig.  5c). Altered 
lymphocyte and granulocyte concentrations but no 
change in platelets were also observed 1 day following the 
stress of a sham surgery. However, the increase in granu-
locytes alone was insufficient to enhance damage; sham 
surgery with increased granulocytes and a mild ischemic 
insult 1  day later produced only mild ischemic changes 
(Fig. 1c).
Discussion
The current results demonstrate the major importance 
of early recurrence of a mild transient ischemic insult 
following an initial TIA. Distinctive in our study, com-
pared to studies of preconditioning, is the investigation 
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Fig. 3 Acute and subacute cortical responses to a single mild ischemic insult. a, b Hematoxylin and eosin (H&E) stained sections from brains 
perfusion fixed at 1 or 3 days following a mild transient middle cerebral artery occlusion (MCAO). c The median and first and third quartiles of the 
damage score was not different statistically between groups. d, e ED1 stained sections from brains 1 and 3 days post MCAO. f Mean numbers of 
ED1 cells stained per field were not different statistically. g, h GFAP stained sections from animals 1 and 3 days post MCAO. i Median and first and 
third quartiles of the GFAP score were similar between groups (P > 0.05). n = 8/group *P < 0.05; **P < 0.005, ipsilateral different from contralateral. 
(Mann–Whitney Rank Sum test)
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severity to cause mild ischemic damage. We found that 
a recurrent mild insult following a TIA in rats produced 
substantially more brain damage when recurrence is 
acute (i.e. 1  day) than with a subacute recovery time of 
3  days between insults. The cause of this difference is 
likely multifactorial and potentially includes an augmen-
tation of damage by systemic inflammatory changes. 
Irrespective of the mechanisms, the results demonstrate 
that the time of mild stroke recurrence can be crucial 
in influencing brain damage and supports urgency for 
determining and implementing optimal stroke preven-
tion management early after TIA to avoid a second 
ischemic event.
Interaction between two Mild Ischemic Insults
The principal finding of the current study was that the 
combined damage produced by multiple mild insults 
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Fig. 4 Cerebral Inflammatory and blood–brain barrier marker changes following a single mild transient MCAO. a Representative sections stained 
from contralateral cortex for the cytokine, tumor necrosis factor (TNF). b, c TNF immunostained sections from ipsilateral cortex at 1 or 3  days post 
MCAO, respectively. d Mean number of TNF stained cells per field is similarly increased at 1 or 3 days post MCAO (n = 8/group). Representative 
positive staining of microglia with Iba1 in contralateral cortex e and ipsilateral cortex at 1 and 3 days post MCAO (f, g). Activated microglia were 
observed at 1 day and these were more numerous at 3 days post MCAO (h, n = 8/group). Double staining of vessels and microglia with tomato 
lectin (i–l) and vessels with endothelial barrier antigen (EBA) (m–p). Staining of microglia with lectin was minimal in the contralateral cortex (e.g. i) 
and increased (e.g. arrows) in ipsilateral cortex at 1 day (j) or 3 days (k) post transient MCAO. l Median scores for lectin staining (n = 8/group).  
m Representative staining of vessels for endothelial barrier antigen (EBA) in contralateral cortex (12 animals with good contralateral positive staining 
quantified). n, o EBA staining in ipsilateral cortex from animals at 1 and 3 days post MCAO. p Reduced percentage of vessels stained with EBA ipsilat-
erally relative to contralaterally (n = 6/group). *P < 0.05; **P < 0.005, ipsilateral different from contralateral. †P < 0.01 lectin stained microglia differ 
between 1 and 3 days post MCAO groups
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the current study, previous studies of multiple ischemic 
insults have generally focussed on studies where the 
first or second insult is a very short preconditioning or 
postconditioning ischemia that alone produces no per-
manent cellular damage; such a non-damaging ischemia 
has protective effects [25–28]. Indeed in the current 
study the group with a sham procedure prior to transient 
MCAO had reduced damage compared to that of a sin-
gle MCAO assessed 3  days later. Using an initial insult 
that is more injurious, one laboratory has examined the 
effects of repeated ischemia in the gerbil using only ani-
mals that displayed neurological signs of stroke after a 
first temporary carotid occlusion and subjecting them 
to additional episodes of the same duration of ischemia 
[29, 30]. Although small numbers (3–5) per group were 
investigated, their results suggested a transition from 
mild to more severe injury with increasing numbers of 
insults and greater damage when second insults were at 
3 or 5 versus 48 h apart. Recently, we used a model of two 
relatively short transient ischemic episodes, produced by 
microclip occlusion of the MCA and separated by 3 days 
to demonstrate an increased damage with recurrent 
stroke compared to a single insult [15]. The present study 
also observed an increase in the damage produced by a 
recurrent compared to a single MCAO, but differences 
were most marked for an acute (1 day) rather than a suba-
cute (3 days) recurrence. Extensive infarction rather than 
partial infarction and/or selective necrosis was produced 
when stroke recurrence was acute rather than subacute. 
In addition to this finding, we observed several differen-
tial systemic and cerebral inflammatory changes at acute 
and subacute times following a mild transient ischemic 
insult providing novel insights into the pathophysiology 
of TIA and potential contributions to recurrent stroke 
damage. These results are of potential relevance clinically 
considering an anticipated rise in the incidence of TIA, 
both due to our ageing population and an escalation in 
number of ischemic stroke patients that will be treated 
with early reperfusion therapy [8–10]. Understanding 
better the pathophysiology of early recurrence is also 
essential considering that the median time for recurrence 
of functional deterioration related to a vascular event fol-
lowing a TIA is 1 day [14]. Furthermore, although debili-
tating strokes are relatively infrequent following a TIA 
alone, when there is a recurrent event, 53  % have been 








































































Fig. 5 Systemic changes following a Single Mild Transient MCAO. A complete blood count of blood samples from naïve animals or animals at 1 or 
3 days post a mild transient MCAO. a The concentration of lymphocytes, presented as a % of total white blood cells, was decreased at 1 day post 
transient MCAO when compared to naïve animals. b The mean concentration of platelets was also decreased at 1 day post MCAO. c The mean 
number of granulocytes, normalized to the total number of white blood cells, was transiently increased at 1 day. d Mean hematocrit was similar in 
all groups. N = 5/group. ‡P < 0.05; ‡‡P < 0.005, different from Naive. †P < 0.05, different from 1 day post MCAO (ANOVA and Bonferroni t-test)
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Physiological and vascular changes
Our physiological measures determined that various 
factors known to influence infarct size such as body 
temperature, blood pressure and blood gases were simi-
lar between the groups and thus are unlikely to account 
for the effect of different timing of recurrent insults on 
brain damage. Although preconditioning ischemia has 
been observed by others to improve blood flow during 
ischemia compared to a single severe ischemic insult 
[32, 33], the levels of cerebral blood flow reduction were 
equivalent during both insults and for both groups. With 
respect to reperfusion, there were no significant statisti-
cal differences in perfusion within the first 5 min of rep-
erfusion. However, there was a variable return of flow to 
baseline, with some animals demonstrating hyperperfu-
sion and this variance was associated with suboptimal 
statistical power requiring caution for deciding the group 
means were the same. Also a limitation presently was 
that only acute reperfusion was monitored and the possi-
bility remains that at a delayed hypoperfusion could have 
adversely influenced damage.
Regarding vascular changes, there was little evidence 
for differences in disruption of the blood brain barrier at 
early versus subacute times. There was a lack of detect-
able extravasation of IgG at either time point in agree-
ment with previous reports of a lack of vasogenic edema 
detectable in T2 magnetic resonance images following a 
mild transient ischemic insult [5, 7]. The reduced stain-
ing for EBA did suggest some endothelial injury at both 1 
and 3 days post a single MCAO. Early ischemic endothe-
lial injury is associated with an acute activation of the 
endothelium resulting in an increased expression of 
endothelial adhesion molecules associated with endothe-
lial injury [21, 24, 34]. However, since reductions in EBA 
were similar at both time points, there was no direct evi-
dence for greater dysfunction in the blood–brain barrier 
at 1 than 3  days to help account for greater enhanced 
damage of a recurrent 1 day insult.
Cerebral inflammatory changes
We also investigated whether the first mild ischemic 
insult could produce factors in the tissue that could either 
augment ischemic damage acutely (i.e. at 1 day) or pro-
vide some later (3 days) neuroprotection. The literature is 
sparse regarding acute glial inflammatory changes in the 
brain following a mild ischemic insult mimicking a TIA. 
At relatively chronic times (1–4 weeks) following a mild 
focal transient ischemia increased astroglial reactivity 
using GFAP has been reported previously [5, 7, 35, 36]. 
Similarly, at chronic times post-insult, microglial activa-
tion detected as positive immunostaining for OX42 (an 
immune marker for CD11b which also stains activated 
neutrophils and microglial derived macrophages) [37] 
was increased within areas of selective necrosis at 2 and 
4 weeks post insult followed by a decline in OX42 stain-
ing thereafter [5, 6, 36]. We investigated acute microglial/
macrophage activation using Iba1, tomato lectin and ED1 
staining and observed a consistent early (1 day) increase 
in Iba1 stained microglia but sparse positive ED-1 stain-
ing in 3/8 animals. Staining for activated microglia/mac-
rophages using Iba1 and lectin staining was increased 
at 3 days compared to 1 day post a mild ischemic insult 
and ED-1 staining was present in 6/8 animals. This sup-
ports that microglial activation occurs as early as 1  day 
post a mild ischemic insult, consistent with previous 
observations of early microglial activation in peri-infarct 
regions i.e. regions which likely experienced mild tran-
sient ischemia; and, this is followed by the appearance of 
macrophages within the core and peri-infarct region at 
3–5 days post-insult [37]. There is a complex and incom-
pletely understood progression of activation of different 
microglial phenotypes (e.g. macrophages that are of an 
M1 or M2 phenotype), however, there is agreement in 
general that activated microglia appear to be involved in 
both necrotic and repair responses [21, 37–39]. Thus it 
is possible that in the present study, increased microglial 
activation observed at 3  days provides some neuropro-
tection and acts to help reduce damage during the sec-
ond insult via expression of anti-inflammatory cytokines 
such as IL-10 or TGF-β and factors such as IGF-1 [21, 
37, 39]. Future elucidation of the pathophysiology of the 
polarity changes of the various immune cells activated 
following ischemia should consider identifying the spe-
cific mediators within the microenvironment in response 
to differing severities of cerebral ischemia—including 
a mild transient ischemia. Presently, evidence was lack-
ing for a potential involvement of a differential release 
of pro-inflammatory neurotoxic cytokines enhancing 
acute recurrent ischemic damage considering staining for 
TNF-alpha tended to be greater rather than less at 3 days.
Systemic inflammation
Examination of peripheral blood following a short tran-
sient ischemia indicated that even a mild ischemic insult 
evoked alterations in inflammatory cells within the blood. 
Although the complex and dynamic immune responses 
post ischemia are still being characterized in detail and 
their roles in affecting ischemic outcomes remain con-
troversial, numerous studies indicate that ischemic 
alterations in peripheral inflammatory cells can modify 
brain damage [21, 23, 24]. Following the mild transient 
ischemia produced currently, we found alterations in the 
concentrations of lymphocytes, granulocytes and plate-
lets in the blood.
Regarding changes in lymphocytes, both our sham 
animals and animals 1  day post a mild ischemic insult 
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demonstrated a decrease in peripheral lymphocytes 
compared to our naïve controls. This is consistent with 
the lymphopenia associated with immune suppression 
and an increased susceptibility to infection that is well 
recognized to occur post stroke in humans and experi-
mental animals [40–43]. The reduction in lymphocytes 
with the current mild transient ischemia produced by 
30 min clip occlusion was rather modest (10–15 %) and 
short lasting compared to the >50  % reduction in lym-
phocytes observed for at least 2 weeks following 60 min 
of transient MCAO in mice using a transient intralumi-
nal thread occlusion [40]. Presently, lymphocyte numbers 
returned towards naïve control levels already by 3  days 
post-insult.
The white blood cell analysis also provided a count of 
polymorphonuclear granulocytes which consists of pre-
dominantly neutrophils along with eosinophils and baso-
phils. The increase in granulocytes observed at 1  day 
post-insult is consistent with reports of increased gran-
ulocytes following stroke in humans and experimental 
animals [41, 43–46]. The origin of the additional granulo-
cytes can vary with the type of injury but includes mobi-
lization from the spleen and bone marrow and potentially 
increased production and decreased apoptosis [34, 37]. 
The mechanism mediating the increase likely includes a 
stress response [23, 41] which is consistent with previous 
reports and our observation of elevated numbers of gran-
ulocytes and decreased numbers of lymphocytes, also in 
animals subjected to sham surgery [40, 47, 48]. With a 
mild transient ischemic insult, we observed an increase 
in granulocytes that was temporary with a normaliza-
tion by 3  days post MCAO. A similar return towards 
baseline was observed in mice with either sham surgery 
or MCAO using a transient ligature [48]. Important to 
note is that the stress induced neutrophilia would appear 
insufficient to enhance damage because a sham surgery 
1  day prior to mild transient MCAO reduced ischemic 
damage indicating that a combination of both transient 
cerebral ischemia and neutrophilia would be involved in 
exacerbating damage.
Indeed, the interaction of granulocytes or neutrophils 
with cerebral ischemia is a complex operation of dynamic 
changes in neutrophil activation at various sites (e.g. vas-
cular and parenchymal) underlying multiple functions 
(e.g. blood–brain barrier disruption, thrombus/clot for-
mation or neurotoxicity) [34]. Both clinical and experi-
mental studies have reported an increased accumulation 
of neutrophils in the brain after an ischemic stroke [34, 
37, 49]; and, there is evidence for their role in enhancing 
brain damage but also evidence for their lack of an effect 
or for producing beneficial effects via neuroprotection 
or an involvement in brain repair e.g. [34, 37, 50–53]. 
This variability may reflect the array of time dependent 
changes in various molecular signals and their interac-
tions on multiple cell types with potential differences 
according to species.
Currently, the neurovascular unit is considered a key 
site of neutrophil action at delayed times following tran-
sient cerebral ischemia. Following transient ischemia, 
Ly6G positive neutrophil infiltration into the brain 
parenchyma was minimal or occurred within the vicin-
ity of vessels [54, 55]. Also following transient ischemia 
in the mouse, homogenized brain samples analyzed 
with flow cytometry demonstrated a delayed (2–3 days) 
increase in neutrophils not present at 1 day [53, 56]. Note 
that neutrophil migration appears to occur sooner and is 
more intense without reperfusion; it has been observed 
early (e.g. at 1  day) following permanent ischemia [47, 
57]. Although there may be a lack of migration into brain 
acutely following a single transient ischemia, granulo-
cyte recruitment, activation and infiltration [34, 37] on 
primed cerebral endothelium may be greatly acceler-
ated by the subsequent flow disruption produced with a 
recurrent ischemic insult. A contribution from platelets 
is also possible as supported by their decrease at 1  day 
compared to 3  days post-insult possibly reflecting con-
tinued activation/interaction with cerebral ischemic 
vasculature. Reduced platelet counts have also been 
observed in stroke patients and there is evidence for their 
interaction with peripheral inflammatory responses and 
ischemic injury [58–60]. Additional research is required 
to clarify the importance of granulocyte and platelet 
interactions and the dynamic changes in injured cerebro-
vascular endothelium following an initial mild ischemic 
insult prior to a second TIA. The possibility for different 
peripheral immune responses occurring with a first TIA 
versus a recurrent stroke/TIA should also be considered 
[61].
Conclusion
To conclude, the production of multiple mild ischemic 
insults with different recovery times between them 
demonstrated an important dependence on the tim-
ing between insults. The damage observed with a short 
recovery of 1 day following a mild transient ischemia sub-
stantially exceeded that with a subacute recovery time of 
3 days. The results might help explain clinical reports of 
increased risk of recurrent stroke in the first day follow-
ing a TIA/minor stroke or the sudden clinical deteriora-
tion observed in some cases soon after stroke [62, 63]. The 
mechanisms involved in the response are likely complex 
involving a progression of systemic and cerebral/vascular 
inflammatory changes after the first mild ischemic insult 
that affect the second insult. Irrespective, the results indi-
cate that in the absence of clinically available therapeutic 
therapy to attenuate injury following a transient ischemic 
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attack or its recurrence, patients should receive immedi-
ate care to best manage and prevent stroke recurrence 
e.g. with early investigation of thromboembolic sources, 
intensive antiplatelet therapies, lipid lowering, and/or 
anticoagulation for cardioembolic stroke.
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